HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stalvey, M. S. Articles by Atkinson, M. A. Search for Related Content PubMed PubMed Citation Articles by Stalvey, M. S. Articles by Atkinson, M. A. Social Bookmarking                What's this?

Cystic Fibrosis Transmembrane Conductance Regulator Deficiency Exacerbates Islet Cell Dysfunction After ß-Cell Injury

¹ Department of Pediatrics, University of Florida, College of Medicine, Gainesville, Florida
² Department of Pathology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville, Florida
³ General Clinical Research Center, University of Florida, College of Medicine, Gainesville, Florida

Address correspondence and reprint requests to Mark Atkinson, PhD, Department of Pathology, University of Florida, College of Medicine, PO Box 100275, Gainesville, FL 32610. E-mail: atkinson{at}ufl.edu

Abbreviations: CFRD, cystic fibrosis–related diabetes; CFTR, cystic fibrosis transmembrane conductance regulator; FABP, fatty acid–binding protein; hCFTR, human CFTR; IPGTT, intraperitoneal glucose tolerance test; STZ, streptozotocin

The cause of cystic fibrosis–related diabetes (CFRD) remains unknown, but cystic fibrosis transmembrane conductance regulator (CFTR) mutations contribute directly to multiple aspects of the cystic fibrosis phenotype. We hypothesized that susceptibility to islet dysfunction in cystic fibrosis is determined by the lack of functional CFTR. To address this, glycemia was assessed in CFTR null (CFTR^–/–), C57BL/6J, and FVB/NJ mice after streptozotocin (STZ)-induced ß-cell injury. Fasting blood glucose levels were similar among age-matched non–STZ-administered animals, but they were significantly higher in CFTR^–/– mice 4 weeks after STZ administration (288.4 ± 97.4, 168.4 ± 35.9, and 188.0 ± 42.3 mg/dl for CFTR^–/–, C57BL/6J, and FVB/NJ, respectively; P < 0.05). After intraperitoneal glucose administration, elevated blood glucose levels were also observed in STZ-administered CFTR^–/– mice. STZ reduced islets among all strains; however, only CFTR^–/– mice demonstrated a negative correlation between islet number and fasting blood glucose (P = 0.02). To determine whether a second alteration associated with cystic fibrosis (i.e., airway inflammation) could impact glucose control, animals were challenged with Aspergillus fumigatus. The A. fumigatus–sensitized CFTR^–/– mice demonstrated similar fasting and stimulated glucose responses in comparison to nonsensitized animals. These studies suggest metabolic derangements in CFRD originate from an islet dysfunction inherent to the CFTR^–/– state.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A Battezzati, P M Battezzati, D Costantini, M Seia, L Zazzeron, M C Russo, V Dacco, S Bertoli, A Crosignani, and C Colombo Spontaneous hypoglycemia in patients with cystic fibrosis Eur. J. Endocrinol., March 1, 2007; 156(3): 369 - 376. [Abstract] [Full Text] [PDF]